Search results
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Digital Journal· 2 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...
Past COVID infections may help protect against certain colds
WJZY via Yahoo News· 2 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
ABC 26 New Orleans· 2 days agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
COVID on the rise again in California, after record-low deaths this spring
San Jose Mercury News· 1 hour agoOnce again it seems like a lot of people are coming down with COVID in the Bay Area, and data shows...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 2 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Hawaii Health Department warns of high COVID activity
Honolulu Star-Advertiser· 1 day agoThe Hawaii Department of Health issued a Wednesday news release reminding the public to be vigilant...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
WSB Radio· 2 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Combined COVID-flu vaccine shows positive results in late-stage trial, Moderna says
WISH-TV Indianapolis· 5 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 1 day agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 1 day agoKP.3 accounts for 25% of cases, while another variant, KP.2, makes up about 22% of cases. Experts...